RCJ, nothing you can say will change Dew's opinion. The design of the next trials will speak for themselves. Dr. Chabner and Dr. Garnick are experienced experts in trial design. Neither you or Dew share that distinction! Dew's example of a financial officer coming on board HEB is not a relevant example. You are absolutely correct in saying that we must wait and see what Dr. Chabner and Dr. Garnick recommend. I agree with you that these outstanding scientists will not allow themselves to be associated with a scam! I look forward to the next trial design which will be aimed at pleasing the FDA and not you, me or Dew!
Market Data 
Markets 
AI
